Twelve-month clinical outcomes after implantation of a new, modular, anterior shape-changing fluid optic intraocular lens

S. Garg, M. T. De Jesus, Laura M. Fletcher, A. Chayet, Enrique Barragán, Patrick Casey
{"title":"Twelve-month clinical outcomes after implantation of a new, modular, anterior shape-changing fluid optic intraocular lens","authors":"S. Garg, M. T. De Jesus, Laura M. Fletcher, A. Chayet, Enrique Barragán, Patrick Casey","doi":"10.1097/j.jcrs.0000000000000935","DOIUrl":null,"url":null,"abstract":"This exploratory study of a new anterior shape-changing presbyopia-correcting intraocular lens demonstrated good outcomes for distance, intermediate, and near vision, low rates of dysphotopsia, and an acceptable safety profile. Purpose: To report the initial safety and effectiveness profile for an anterior shape-changing, modular IOL, Juvene IOL (JIOL), for the treatment of aphakia and presbyopia after removal of the natural crystalline lens due to cataract. Setting: 2 private practices in Monterrey and Tijuana, Mexico. Design: Exploratory prospective multicenter open-label noncomparative clinical trial. Methods: A convenience sample of patients aged 50 to 80 years with planned cataract surgery was recruited to undergo unilateral or bilateral implantation with the JIOL. Patients were required to complete an informed consent and be able to dilate to at least 6.0 mm pharmacologically, be in good overall health, and have no significant eye health history to qualify. Visual acuities, defocus curves, and contrast sensitivity were measured for all patients 12 months postoperatively. Results: 51 of 58 eyes completed the 12-month visit. Intraoperative complication rates were extremely low (n = 1; missed base lens tab). The most frequent adverse events (AEs) were prolonged inflammation (N = 6) and cystoid macular edema (N = 4); all AEs were resolved without sequelae by the 12-month visit. The mean monocular logMAR corrected distance visual acuity, distance-corrected intermediate visual acuity, and distance-corrected near visual acuity were 0.01, 0.08, and 0.24, respectively. Defocus testing showed visual acuity > 20/40 from approximately +1.00 through −2.00 diopters. Binocular implantation (n = 16) provided superior performance over monocular implantation. Conclusions: The JIOL offers a new solution to treat presbyopia, providing clear functional vision performance across a range of distances with an acceptable initial safety profile.","PeriodicalId":15233,"journal":{"name":"Journal of Cataract & Refractive Surgery","volume":"1 1","pages":"1134 - 1140"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cataract & Refractive Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/j.jcrs.0000000000000935","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

This exploratory study of a new anterior shape-changing presbyopia-correcting intraocular lens demonstrated good outcomes for distance, intermediate, and near vision, low rates of dysphotopsia, and an acceptable safety profile. Purpose: To report the initial safety and effectiveness profile for an anterior shape-changing, modular IOL, Juvene IOL (JIOL), for the treatment of aphakia and presbyopia after removal of the natural crystalline lens due to cataract. Setting: 2 private practices in Monterrey and Tijuana, Mexico. Design: Exploratory prospective multicenter open-label noncomparative clinical trial. Methods: A convenience sample of patients aged 50 to 80 years with planned cataract surgery was recruited to undergo unilateral or bilateral implantation with the JIOL. Patients were required to complete an informed consent and be able to dilate to at least 6.0 mm pharmacologically, be in good overall health, and have no significant eye health history to qualify. Visual acuities, defocus curves, and contrast sensitivity were measured for all patients 12 months postoperatively. Results: 51 of 58 eyes completed the 12-month visit. Intraoperative complication rates were extremely low (n = 1; missed base lens tab). The most frequent adverse events (AEs) were prolonged inflammation (N = 6) and cystoid macular edema (N = 4); all AEs were resolved without sequelae by the 12-month visit. The mean monocular logMAR corrected distance visual acuity, distance-corrected intermediate visual acuity, and distance-corrected near visual acuity were 0.01, 0.08, and 0.24, respectively. Defocus testing showed visual acuity > 20/40 from approximately +1.00 through −2.00 diopters. Binocular implantation (n = 16) provided superior performance over monocular implantation. Conclusions: The JIOL offers a new solution to treat presbyopia, providing clear functional vision performance across a range of distances with an acceptable initial safety profile.
新型模块化前晶状体液体光学人工晶状体植入术后12个月的临床效果
一种新型前晶状体形状改变矫正老花眼人工晶状体的探索性研究表明,对远视、中视和近视的治疗效果良好,近视发生率低,安全性可接受。目的:报道一种前部形状改变的模块化人工晶状体,少年人工晶状体(JIOL),用于治疗白内障自然晶状体摘除后无晶状体和老花眼的初步安全性和有效性。背景:墨西哥蒙特雷和提华纳的两家私人诊所。设计:探索性前瞻性多中心开放标签非比较临床试验。方法:选取年龄在50 ~ 80岁的原计划白内障手术患者,进行单侧或双侧人工晶状体植入术。患者需要填写知情同意书,药理学上能够扩张到至少6.0 mm,整体健康状况良好,并且没有明显的眼部健康史。术后12个月测量所有患者的视力、离焦曲线和对比敏感度。结果:58只眼中有51只完成了12个月的随访。术中并发症发生率极低(n = 1;错过的基础镜头标签)。最常见的不良事件(ae)是持续炎症(N = 6)和黄斑囊样水肿(N = 4);随访12个月,所有ae均得到解决,无后遗症。平均单眼logMAR矫正距离视力、矫正中间视力和矫正近视力分别为0.01、0.08和0.24。离焦测试显示,在大约+1.00到−2.00屈光度范围内,视力> 20/40。双眼植入术(n = 16)优于单眼植入术。结论:JIOL为治疗老花眼提供了一种新的解决方案,在一定距离范围内提供清晰的功能性视力表现,并具有可接受的初始安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信